Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC
Clinical trial NCT07711470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07711470
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.